Navigation Links
21st Century Oncology Renews Research Commitment with Massachusetts General Hospital
Date:8/20/2013

Fort Myers, FL and Scottsdale, AZ (PRWEB) August 20, 2013

21st Century Oncology today announced it will more closely combine cancer research initiatives with Massachusetts General Hospital (MGH), the original and largest teaching affiliate of Harvard Medical School (HMS).

Currently, 21st Century Oncology, the largest U.S. radiation therapy provider, conducts cancer research alongside MGH within the framework of the Radiation Therapy Oncology Group (RTOG), a national cancer research organization funded by the National Cancer Institute (NCI) to increase the survival rates and improve the quality of life of patients diagnosed with cancer.

In February 2014, the NCI will implement a reorganized cooperative structure, combining three specialized oncology research bodies into one, all-encompassing clinical research collective. The National Surgical Adjuvant Breast and Bowel Project (NSABP), the RTOG, and the Gynecologic Oncology Group (GOG) will become NRG Oncology.

“We are pleased to continue this relationship with Massachusetts General Hospital under the NRG reorganization,” says Daniel Dosoretz, MD, FACR, FACRO, President, CEO and Co-Founder of 21st Century Oncology. “The research and clinical trials we conduct today will improve outcomes for patients with cancer moving forward.”

21st Century Oncology is conducting clinical research trials at sites across the country and assessing the effectiveness of various cancer treatments. “Physicians are currently evaluating advanced therapy in breast cancer, prostate cancer and bladder cancer and look forward to expanding to other sites including lung cancer,” says Steven Finkelstein, MD, National Director, 21st Century Oncology Translational Research Consortium.

“I am pleased as the Principal Investigator of the MGH/HMS, full membership within the RTOG, to be continuing our relationship with 21st Century Oncology to increase the participation for patients on clinical trials as we transition to NRG Oncology in 2014,” says William U. Shipley, MD, FACR, FASTRO who is the Andres Soriano Professor of Radiation Oncology at Harvard Medical School and the MGH. “It is this kind of collaboration and cooperation among leading researchers that will help advance cancer treatment for our patients and save more lives.”

About 21st Century Oncology:
21st Century Oncology is the foremost provider of cancer care services across multiple modalities, and the largest radiation oncology provider. For more than 30 years, 21st Century Oncology has been committed to providing state-of-the-art, academic level treatment options in a patient-centric setting focused on continuous innovation. Headquartered in Fort Myers, Florida, the physician-led company operates in 15 states and 7 countries, with an extensive network of over 300 locations, including approximately 131 radiation therapy facilities. 21st Century Oncology employs or is affiliated with hundreds of physicians in a broad spectrum of cancer-related specialists—working together to deliver the most advanced integrated cancer care. For more information about research and clinical trials with 21st Century Oncology, visit http://www.21stCenturyOncology.com/Research-Outcomes.

About Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $775 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine. For more information about Massachusetts General Hospital, visit http://www.MassGeneral.org.

About NRG Oncology
NRG Oncology is a nonprofit research organization formed to conduct oncologic clinical research and to broadly disseminate study results for informing clinical decision-making and healthcare policy. It brings together the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)—each recognized internationally as a research leader.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11039720.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Grace Century, FZ LLC Announces The Quantum Group’s Submission for EMR Platform MU1 Certification
2. Net Worth TV to Air Software Innovations for the 21st Century
3. Narconon Gabbiano Celebrates a Quarter Century of Saving Lives in Lecce, Italy
4. RKNet Studios Announced Cognitions Bridge Games to Help Students Develop Cognitive Abilities to Support Learning in the 21st Century Education
5. Grace Century’s #EHR Project with Quantum Group Sees Final U.S. Health and Human Services Ruling as Potential Boon to Patent Portfolio and Revolutionary Platform PWeR2.0
6. Creighton Professor Explores Bioethics For The 21st Century In Updated Book
7. New Century Coal Signs Option Adding Over 5 Million Tons; Set to Become Industry Reserve Leaders
8. Study finds newspapers have changed coverage of ice hockey concussions over last quarter-century
9. International Conference on Governance of Tobacco in the 21st Century
10. JNL Fusion Coined "Workout of the Century" by Top Acupuncturist, Healer & Holistic Expert Janine Jozwiak, Who Owns and Runs Highly Sought After Wellness Clinic
11. Citizen science more than a century later: Ordinary people go online to track Gulf oil spill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/20/2017)... ... ... New ADA Portable Motion Trek BP 300 Lift. Built for durability, this pool lift is ... be wheeled out of the way and stored when not in use. It is freestanding ... feedback from customers into specific enhancements and created a new product that is built directly ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Bionic Sports Nutrition ... walks of life, announced it had a successful January ECRM Trade Show in Hilton ... the United States, which allows it to provide its products to all clients at ...
(Date:1/20/2017)... ... , ... "TransFlare 4K Mystique comes with 44 colorful mysterious transitions that are ... Austin - CEO of Pixel Film Studios. , TransFlare 4K Mystique contains 44 ... flare and light leak transitions have a very high-dynamic range for super smooth falloff. ...
(Date:1/20/2017)... ... January 20, 2017 , ... “I Forgive You”: a fine examination of how ... You” is the creation of published author, Stephen Miller, who, for over ten long years ... given to him. Born in Trinidad and Tobago, he has been serving the Lord for ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... The global immunomodulators market is expected ... to a new study by Grand View Research, ... driven by high R&D investments employed by the ... new and therapeutically advanced drugs. This is believed ... unprecedented rate into the immunomodulators market hence providing ...
(Date:1/19/2017)... Jan. 19, 2017 Report Details ... Alzheimer,s ... Leading Companies – our new study reveals trends, R&D ... and events affecting the Alzheimer,s disease therapeutics and diagnostics ... these key questions: - How is the Alzheimer,s disease ...
(Date:1/19/2017)... 2017 According to a study conducted by ... to witness a CAGR of 6.5% during the forecast period 2016-2024. ... continue to be the leading market for cryotherapy globally during the ... Highlights ... ensuring affordable and adequate supply of gas in order to provide ...
Breaking Medicine Technology: